ADMA
ADMA Biologics Inc
9.70$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 59.8% | 66.0% | 63.3% | 60.1% | 59.7% | 128.1% | 248.4% | 134.6% | 145.2% | 98.6% | 77.1% | 65.6% | 48.5% | 42.6% | |
| – | – | – | – | – | – | 40.2% | 34.0% | 36.7% | 39.9% | 40.3% | -28.1% | -148.4% | -34.6% | -45.2% | 1.4% | 22.9% | 34.4% | 51.5% | 57.4% | |
| – | – | – | – | – | – | 310.3% | 303.3% | 160.9% | 97.7% | 72.1% | 27.4% | 23.1% | 8.0% | 14.0% | 4.5% | 2.3% | 1.3% | 0.4% | 0.9% | |
| – | – | – | – | – | – | 281.0% | 142.3% | 81.5% | 94.0% | 79.7% | 79.5% | 132.5% | 88.3% | 83.0% | 68.2% | 45.6% | 22.2% | 17.4% | 18.0% | |
| – | – | – | – | – | – | 747.5% | 524.4% | 307.5% | 256.1% | 202.9% | 140.9% | 206.5% | 106.5% | 108.6% | 73.6% | 48.4% | 26.1% | 18.9% | 19.9% | |
| – | – | – | – | – | – | -707.4% | -490.4% | -270.8% | -216.1% | -162.6% | -172.7% | -354.9% | -141.1% | -153.8% | -72.1% | -25.5% | 8.4% | 32.6% | 37.5% | |
| – | – | – | – | – | – | 2.7% | 20.2% | 21.7% | 25.7% | 21.0% | 14.4% | 32.5% | 30.6% | 28.4% | 16.1% | 12.5% | 9.7% | 3.3% | 1.4% | |
| – | – | – | – | – | – | -708.2% | -506.2% | -293.5% | -250.4% | -183.1% | -192.3% | -387.1% | -164.5% | -179.4% | -88.5% | -42.8% | -10.9% | 29.5% | 35.8% | |
| – | – | – | – | – | – | -55.2% | 15.8% | -9.3% | 34.2% | 20.5% | 19.5% | 32.1% | 29.9% | 28.1% | 15.8% | 12.5% | 3.2% | -16.9% | 7.0% | |
| – | – | – | – | – | – | -653.0% | -506.2% | -284.2% | -250.4% | -183.1% | -192.3% | -387.1% | -164.5% | -179.4% | -88.5% | -42.8% | -10.9% | 46.4% | 28.8% | |
| – | – | – | – | – | – | -689.2% | -479.2% | -267.6% | -218.1% | -157.6% | -172.7% | -334.3% | -122.8% | -141.7% | -65.6% | -25.6% | 2.0% | 34.6% | 38.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.